Systemic tumor embolism mimicking gefitinib ('IRESSA')-induced interstitial lung disease in a patient with lung cancer.

导出 LinkOut

翻译打印收藏纠错

作者： Shigeki,Umemura ^[1] ; Daizo,Kishino ; Masahiro,Tabata ; Katsuyuki,Kiura ; Katsuyuki,Hotta ; Kenji,Nishii ; Yasushi,Tanimoto ; Arihiko,Kanehiro ; Kenji,Notohara ; Hiroshi,Ueoka ; Mitsune,Tanimoto

作者单位： Department of Hematology, Oncology and Respiratory Medicine Okayama University Graduate School of Medicine and Dentistry, Japan. ^[1]

主题词腺癌(Adenocarcinoma);抗肿瘤药(Antineoplastic Agents);诊断, 鉴别(Diagnosis, Differential);人类(Humans);肺疾病, 间质性(Lung Diseases, Interstitial);肺肿瘤(Lung Neoplasms);男(雄)性(Male);中年人(Middle Aged);肿瘤细胞, 循环(Neoplastic Cells, Circulating);喹唑啉类(Quinazolines)

DOI 10.2169/internalmedicine.44.979

PMID 16258216

发布时间 2019-06-06

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览4

Internal medicine (Tokyo, Japan)

2005年44卷9期

979-82页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

Systemic tumor embolism mimicking gefitinib ('IRESSA')-induced interstitial lung disease in a patient with lung cancer.

Internal medicine (Tokyo, Japan)

相似文献

Internal medicine (Tokyo, Japan)

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Systemic tumor embolism mimicking gefitinib ('IRESSA')-induced interstitial lung disease in a patient with lung cancer.

Internal medicine (Tokyo, Japan)

相似文献

Internal medicine (Tokyo, Japan)

相关期刊

检索历史清除